513 related articles for article (PubMed ID: 27013226)
1. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
Chopra G; Samudrala R
Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
[TBL] [Abstract][Full Text] [Related]
2. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
Hudson ML; Samudrala R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
[TBL] [Abstract][Full Text] [Related]
3. Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform.
Sethi G; Chopra G; Samudrala R
Mini Rev Med Chem; 2015; 15(8):705-17. PubMed ID: 25694071
[TBL] [Abstract][Full Text] [Related]
4. Combating Ebola with Repurposed Therapeutics Using the CANDO Platform.
Chopra G; Kaushik S; Elkin PL; Samudrala R
Molecules; 2016 Nov; 21(12):. PubMed ID: 27898018
[TBL] [Abstract][Full Text] [Related]
5. cando.py: Open Source Software for Predictive Bioanalytics of Large Scale Drug-Protein-Disease Data.
Mangione W; Falls Z; Chopra G; Samudrala R
J Chem Inf Model; 2020 Sep; 60(9):4131-4136. PubMed ID: 32515949
[TBL] [Abstract][Full Text] [Related]
6. Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design.
Mangione W; Samudrala R
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621144
[TBL] [Abstract][Full Text] [Related]
7. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
[TBL] [Abstract][Full Text] [Related]
8. CANDO and the infinite drug discovery frontier.
Minie M; Chopra G; Sethi G; Horst J; White G; Roy A; Hatti K; Samudrala R
Drug Discov Today; 2014 Sep; 19(9):1353-63. PubMed ID: 24980786
[TBL] [Abstract][Full Text] [Related]
9. Fingerprinting CANDO: Increased Accuracy with Structure- and Ligand-Based Shotgun Drug Repurposing.
Schuler J; Samudrala R
ACS Omega; 2019 Oct; 4(17):17393-17403. PubMed ID: 31656912
[TBL] [Abstract][Full Text] [Related]
10. A Deep-Learning Proteomic-Scale Approach for Drug Design.
Overhoff B; Falls Z; Mangione W; Samudrala R
Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959678
[TBL] [Abstract][Full Text] [Related]
11. Optimal COVID-19 therapeutic candidate discovery using the CANDO platform.
Mangione W; Falls Z; Samudrala R
Front Pharmacol; 2022; 13():970494. PubMed ID: 36091793
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
Zhang W; Bai Y; Wang Y; Xiao W
Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
[TBL] [Abstract][Full Text] [Related]
13. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
[TBL] [Abstract][Full Text] [Related]
14. Exploration of interaction scoring criteria in the CANDO platform.
Falls Z; Mangione W; Schuler J; Samudrala R
BMC Res Notes; 2019 Jun; 12(1):318. PubMed ID: 31174591
[TBL] [Abstract][Full Text] [Related]
15. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.
Lim H; He D; Qiu Y; Krawczuk P; Sun X; Xie L
PLoS Comput Biol; 2019 Jun; 15(6):e1006619. PubMed ID: 31206508
[TBL] [Abstract][Full Text] [Related]
16. Computational Multitarget Drug Design.
Zhang W; Pei J; Lai L
J Chem Inf Model; 2017 Mar; 57(3):403-412. PubMed ID: 28166637
[TBL] [Abstract][Full Text] [Related]
17. In silico methods to address polypharmacology: current status, applications and future perspectives.
Lavecchia A; Cerchia C
Drug Discov Today; 2016 Feb; 21(2):288-98. PubMed ID: 26743596
[TBL] [Abstract][Full Text] [Related]
18. Computational polypharmacology: a new paradigm for drug discovery.
Chaudhari R; Tan Z; Huang B; Zhang S
Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking: Shifting Paradigms in Drug Discovery.
Pinzi L; Rastelli G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867
[TBL] [Abstract][Full Text] [Related]
20. Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning.
Brylinski M
Methods Mol Biol; 2017; 1611():109-122. PubMed ID: 28451975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
